These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 4973120)
1. Detection of sensitizing tissue culture components in viral vaccines. Wilson S; Weber JC; Aprile MA; Macmorine HG J Allergy; 1968 Dec; 42(6):319-29. PubMed ID: 4973120 [No Abstract] [Full Text] [Related]
2. Sensitizing versus immunizing properties of inactivated measles vaccine. Wilson S; Aprile MA Prog Immunobiol Stand; 1970; 4():657-60. PubMed ID: 4991597 [No Abstract] [Full Text] [Related]
3. Sensitization of guinea-pigs to measles vaccines. Aprile MA; Kadar D; Wilson S Clin Exp Immunol; 1969 Nov; 5(5):531-9. PubMed ID: 4982816 [TBL] [Abstract][Full Text] [Related]
4. [Biology of attenuated mumps, rubella, measles and rabies viruses. Comparative considerations on the methods of attenuation of their virulence]. Ciaccio G Riv Biol; 1970; 63(1):87-129. PubMed ID: 4996066 [No Abstract] [Full Text] [Related]
5. Japanese encephalitis purified vaccine. II. Purity of the mouse brain vaccine purified by ultracentrifugation. Yamashita T; Ishikawa N; Hojo F; Shimada F; Ono K Biken J; 1970 Mar; 13(1):25-38. PubMed ID: 4193086 [No Abstract] [Full Text] [Related]
6. Viral vaccines: various cell substrates and long-term prospective studies. Kirschstein RL; Petricciani JC Adv Exp Med Biol; 1972; 31(0):197-206. PubMed ID: 4212515 [No Abstract] [Full Text] [Related]
7. Clinical experience with vaccines produced in the human diploid cell line WI-38. Andzaparidze OG Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367 [No Abstract] [Full Text] [Related]
8. Immunoprophylaxis of viral infections in childhood. Ogra PL Indian J Pediatr; 1970 Aug; 37(271):376-94. PubMed ID: 4099208 [No Abstract] [Full Text] [Related]
9. Tuberculin skin sensitivity in guinea-pigs given some live viral vaccines. Stárek M; Průchová J Prog Immunobiol Stand; 1967; 3():363-4. PubMed ID: 5379957 [No Abstract] [Full Text] [Related]
11. Production and testing of rubella virus vaccine. Prepared on WI-38 cell cultures. Tint H; Rosanoff EI Am J Dis Child; 1969 Aug; 118(2):367-71. PubMed ID: 4978515 [No Abstract] [Full Text] [Related]
12. The demonstration of the sensitizing effect of the residual animal serum content of vaccines. Erdös L; Láng CS; Jaszovszky I; Nyerges G Ann Immunol Hung; 1973; 17():79-83. PubMed ID: 4218939 [No Abstract] [Full Text] [Related]
13. Live attenuated rubella virus vaccines prepared in duck embryo cell culture. I. Development and clinical testing. Buynak EB; Hilleman MR; Weibel RE; Stokes J JAMA; 1968 Apr; 204(3):195-200. PubMed ID: 4172467 [No Abstract] [Full Text] [Related]
14. Immunization practices and controversies 1981: Part 1-The "big seven" vaccines. Backes CR J Am Osteopath Assoc; 1981 May; 80(9):595-603. PubMed ID: 7251409 [No Abstract] [Full Text] [Related]
15. Toward control of viral infections of man. Hilleman MR Science; 1969 May; 164(3879):506-14. PubMed ID: 4305076 [No Abstract] [Full Text] [Related]
16. New vaccines and vaccination policies. Pichichero ME; Green JL; Francis AB; Marsocci SM; Disney FA Pediatr Ann; 1990 Dec; 19(12):686-8, 690-1, 694. PubMed ID: 2177872 [No Abstract] [Full Text] [Related]
17. Review of studies with inactivated rubella virus. Beck ES Am J Dis Child; 1969 Aug; 118(2):328-33. PubMed ID: 4979428 [No Abstract] [Full Text] [Related]
18. Bacteriophages and endotoxin in licensed live-virus vaccines. Moody EE; Trousdale MD; Jorgensen JH; Shelokov A J Infect Dis; 1975 May; 131(5):588-91. PubMed ID: 805187 [TBL] [Abstract][Full Text] [Related]